The company is developing two manufacturing and developmentfacilities that will add just over 22,000 sf to its complex.


The firm said this week it has all but finished its 10,300-sfmanufacturing center. The building incorporates robotics technologyand is designed for the production of gene therapy products. Avigenplans to finish its second building, a 12,000-sf processdevelopment facility, in November.


The company reported increased losses of $15 million in Q2 dueto less grant funding, but has raised $75 million in privatefunding during fiscal 2000.

Want to continue reading?
Become a Free ALM Digital Reader.

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.